You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 睿智醫藥(300149.SZ)5日累跌逾21% 終止“蘇州睿智醫藥CRO”項目
格隆匯 01-24 11:16
格隆匯1月24日丨睿智醫藥(300149.SZ)跌近5%,報13.52元,近5日累跌逾21%,最新總市值68億元。睿智醫藥上週二公吿稱決定終止“蘇州睿智醫藥CRO”項目。就此,有投資者在互動平台提出質疑稱,開發這個項目是否一開始就是為了配合14號的股東拉高減持的?公司回覆稱,終止投資“蘇州睿智醫藥CRO”項目是公司結合近期資金使用計劃,根據公司實際情況作出的決定。此外,睿智醫藥此前承諾的股份回購計劃也未達回購計劃下限,公司致歉。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account